Cargando…
Prognostic Score-based Clinical Factors and Metabolism-related Biomarkers for Predicting the Progression of Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is a common malignant tumor representing more than 90% of primary liver cancer. This study aimed to identify metabolism-related biomarkers with prognostic value by developing the novel prognostic score (PS) model. Transcriptomic profiles derived from TCGA and EBIArray...
Autores principales: | Yan, Jia, Shu, Ming, Li, Xiang, Yu, Hua, Chen, Shuhuai, Xie, Shujie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518001/ https://www.ncbi.nlm.nih.gov/pubmed/33013158 http://dx.doi.org/10.1177/1176934320951571 |
Ejemplares similares
-
MicroRNA-1205 Suppresses Hepatocellular Carcinoma Cell Proliferation via a CSNK2B/CDK4 Axis
por: Li, Xiang, et al.
Publicado: (2023) -
A Molecular Hepatocellular Carcinoma Prognostic Score System Precisely Predicts Overall Survival of Hepatocellular Carcinoma Patients
por: Jia, Jie, et al.
Publicado: (2022) -
Modularity of the metabolic gene network as a prognostic biomarker for hepatocellular carcinoma
por: Ye, Fengdan, et al.
Publicado: (2018) -
The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma
por: Kinoshita, Akiyoshi, et al.
Publicado: (2013) -
Nuf2 Is a Prognostic-Related Biomarker and Correlated With Immune Infiltrates in Hepatocellular Carcinoma
por: Xie, Xingwei, et al.
Publicado: (2021)